An interventional study of Metacognitive Training Jumping to Conclusion and Group discussion in Schizophrenia and Psychotic Disorders, sponsored by University of Warsaw. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-04-22.
Sponsored by University of Warsaw · Not applicable, Interventional, and Treatment
The purpose of this study is to determine whether modules of Metacognitive Training: Jumping to Conclusions and To empathize... are effective in the treatment of patients with schizophrenia. Also it was investigated whether these modules have specific impact on cognitive biases severity.
Investigators employ randomized controlled trial design. Patients in ward were recruited for the study in three waves. In each wave patients were assessed pre-intervention, then randomly allocated in one of three groups: with modules of Metacognitive Training or control group. Then patients were assessed post-intervention.
3,563 studies on the registry are indexed under Schizophrenia; 491 are open to participants now.
This study's enrollment of 38 is below the median of 71 across 2,944 interventional studies indexed under Schizophrenia.
Browse Schizophrenia studies →University of Warsaw is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Metacognitive Training Jumping to conclusions module
Behavioral: Metacognitive Training Jumping to Conclusion
Metacognitive Training To empathize... module
Behavioral: Metacognitive Training To Empathize
group discussion of current events
Behavioral: Group discussion
Therapeutical intervention based on cognitive-behavioural therapy paradigm. Addresses cognitive bias of schizophrenia patients - jumping to conclusion.
Group discussion of current events
Therapeutical intervention based on cognitive-behavioural therapy paradigm. Addresses cognitive bias of schizophrenia patients - Theory of Mind deficits.
Fish Task
variation of Beads Task used for measurement of jumping to conclusion
Time frame: up to 3h after intervention
Reading the Mind in the Eyes Test
used for measurement of Theory of Mind aspects
Time frame: up to 3h after intervention
Cognitive Biases Questionnaire for Psychosis
used for measurement of cognitive biases characteristic for psychotic patients
Time frame: up to 3h after intervention
Symptom Checklist 27 plus
screening tool for psychopathology symptoms
Time frame: up to 3h after intervention
Paranoia Checklist
questionnaire used for assessment of paranoid ideation
Time frame: up to 3h after intervention
No study locations are listed for this record.
Plan to share: No
This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Warsaw